Molecular biologists reported Wednesday that they had grown prostates in mice from single cells, marking an important step forward in the quest to grow transplant tissue in the lab.
The four-person team at the Californian biotechnology firm Genentech said they achieved the feat after identifying a primitive, powerful cell called a stem cell in mouse prostates.
The cell, known by its marker CD117, was transplanted below the kidney in lab mice, according to their study, published online by the British-based science journal Nature.
Of 97 of these single-cell transplants, 14 functioning prostates developed.
Stem cells have unleashed enormous interest in recent years because of their theoretical potential to grow specific cells that can be used to replace tissue damaged by disease or accident.
The biggest focus has been on stem cells at the embryonic stage as these are "pluripotent", meaning that they can become any tissue in the body.
There are also "unipotent" adult stem cells, which are already programmed to divide into specific cells, which is the case in this research.
However, isolating these unipotent cells and getting them to regenerate successfully into the desired tissue in living animals has proven a major hurdle.
In 2006, two teams of scientists made a breakthrough in growing a mouse mammary gland from a single stem cell.
The Genentech researchers suspect that men also have a potential population of CD117 stem cells, although only further work will determine whether these cells can tracked down and used as a regenerative source.
The prostate is a small gland located just below the bladder that helps make seminal fluid and expel semen. Prostate cancer is a leading form of cancer in developed countries.
© 2008 AFP
Related stories:
Scientists call up stem cell troops to repair the body using new drug combinations
Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal
Cell Stem Cell.
Gene abnormality found to predict childhood leukemia relapse
Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in the gene, called IKZF1 or IKAROS, lead to leukemia relapse, the findings are likely to provide the basis for future diagnostic tests to assess the risk of treatment failure. By using a molecular test to identify this genetic marker in ALL patients, physicians should be better able to assign patients to appropriate therapies.
Embryonic Heart Cells Thrive Only in an Environment That's Just Right
(PhysOrg.com) -- Cellular engineers at the University of Pennsylvania have determined that cardiomyocytes, the specialized cells that form the heart muscle, thrive when cultured in an environment that mimics their own elastic nature but falter, weaken or die when “grown” on stiffer or softer materials.
Converting adult somatic cells to pluripotent stem cells using a single virus
A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process. The result is a powerful laboratory tool and a significant step toward the application of embryonic stem cell-like cells for clinical purposes such as the regeneration of organs damaged by inherited or degenerative diseases, including emphysema, diabetes, inflammatory bowel disease, and Alzheimer's Disease.
'Scrawny' gene keeps stem cells healthy
(PhysOrg.com) -- Stem cells are the body's primal cells, retaining the youthful ability to develop into more specialized types of cells over many cycles of cell division. How do they do it? Scientists at the Carnegie Institution have identified a gene, named scrawny, that appears to be a key factor in keeping a variety of stem cells in their undifferentiated state. Understanding how stem cells maintain their potency has implications both for our knowledge of basic biology and also for medical applications. The results will be published in the January 9, 2009 print edition of
Science.
Testes stem cell can change into other body tissues, study shows
Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes. The cells bear a striking resemblance to embryonic stem cells — they can differentiate into each of the three main types of tissues of the body — but the researchers caution against viewing them as one and the same.
Scientists can now differentiate between healthy cells and cancer cells
One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. But a new study by McMaster University researchers has provided insight into how scientists might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells.
Researchers develop novel glioblastoma mouse model
Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma—the most common and deadly brain cancer in humans—that closely resembles the development and progression of human brain tumors that arise naturally.